# | ||||
---|---|---|---|---|
1 | CMI2T IA Harmless Clostridium bacteria as a highly targeted, continuous delivery system for immunomodulatory anti-cancer drugs | 2017 | 115˙625.00 | 115˙625.00 |
The Institution DUALTPHARMA has been involved also in the following Horizon 2020 projects.